Vancouver, British Columbia – TheNewswire - May 13, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (OTC:LEXTF) announces that its board of directors approved the consolidation of the common shares of the Company on the ratio of five (5) pre-consolidated shares for one (1) post-consolidated share. The effective date and timing of the share consolidation will be determined and announced at a later date.
On Behalf of the Board of Directors
LEXSTON LIFE SCIENCES CORP.
Jagdip Bal Chief Executive Officer
Telephone: (604) 928-8913
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Copyright (c) 2022 TheNewswire - All rights reserved.
